Australian biotech market today 26.03.09
Thursday, 26 March, 2009
The pharma and biotech index is up 2.35 per cent at 3.00pm on a generally positive day for the share market.
Cochlear (ASX:COH) is up 63c and CSL (ASX:CSL) is up 79c, while Resmed (ASX:RMD) has had smaller gains.
Progen (ASX:PGL) is up a bit on news of its share buyback. Alchemia (ASX:ACL) is up a touch to 29c and Genera Biosystems (ASX:GBI) is up 5c, both on the back of new share options.
Peplin (ASX:PLI) is up 4c on small trades while Sonic Healthcare (ASX:SHL) is up a cent to $11.32.
ChemGenex (ASX:CXS) is down slightly, as is Novogen (ASX:NRT).
Scientists uncover how cancer cells hide from immune system
By targeting the RNA helicase known as DDX6, scientists could enable the immune system to...
Vanillin flavouring in vapes may disrupt embryo development
Vanillin — a common flavouring chemical in e-cigarettes — may disrupt the normal...
Heart valve tissues created from stem cells
The breakthrough should help advance our understanding into how human heart valves develop,...
